The Department of Pathology and Laboratory Medicine at Roswell Park seeks to recruit an academic hematopathologist at the assistant or associate professor rank with fellowship training and board certification /eligibility (Hematology - American Board of Pathology) to support a rapidly growing hematopathology service and expanding clinical and research programs. The Division supports the department's academic mission, is collegial, collaborative, and fast paced.
The successful candidate will join a hematopathology staff of three fellowship-trained and board certified hematopathologists, four certified technologists and two technicians with an overall clinical volume of more than 4500 cases per year.
The hematopathology clinical service is divided among bone marrow transplant, myeloid, lymphoid, and plasma cell disorders. State of the art ancillary services include flow cytometry, molecular diagnostics, and conventional cytogenetics support the clinical mission. The interactions are supportive and collegial integrating morphology, flow cytometry, cytogenetics, and molecular findings, including FISH, into the reports. Hematopathologists are a key component of the clinical delivery team providing consultative services to Roswell Park's medical oncologists.
Educational opportunities include teaching medical students, residents, fellows, and international scholars visiting the department. In addition, the Center for Immunotherapy and Cancer Center Support Grant resources provide abundant opportunities for cross-disciplinary basic and translational research collaborations.
Roswell Park, founded in 1898, is the first and oldest National Comprehensive Cancer Center. Since its inception, Roswell Park has provided state-of-the-art cancer diagnosis and treatment, conducted basic, translational, and clinical research, and pioneered new treatment modalities.
The successful candidate will be expected to provide the full range of hematopathology expertise including interpretation of flow cytometry. In addition, participation in support of the Cancer Center’s multidisciplinary tumor boards and translational research activities is expected. Development of an independent research program, either clinical or translational is encouraged and will be supported. Candidates must be AP or AP/CP board certified and have successfully completed an ACGME accredited hematopathology fellowship leading to ABP board certification or eligibility. Attainment of a New York State Medical license will be required.